Where is the regorafenib regofinib regofinib Chinese manual?

Updated on healthy 2024-04-28
2 answers
  1. Anonymous users2024-02-08

    RegorafenibInstruction manual:

    Main ingredient] regorafenib.

    Properties】 40 mg film-coated tablets.

    Indications Indications] Stivarga is a kinase inhibitor indicated for patients with metastatic colorectal cancer (CRC) who have previously received fluoropyrimidine-, oxaliplatin, and irinotecan-based chemotherapy, an anti-VEGF, and, as in the KRAS wild-type, an anti-EGFR.

    Specification and model] 40mg*28s

    Dosage] (1) Recommended dose: 160 mg orally, once a day for the first 21 days of a 28-day course of treatment. (2) Take stivarga (a low-fat breakfast) with food.

    Adverse reactions] The most common adverse reactions (30%) were fatigue, decreased appetite and food intake, hand-foot** reaction (HFSR) [palmar foot redness and swelling (PPE)], diarrhea, oral mucositis, weight loss, infection, hypertension, and dysphonia.

    Contraindications] are not clear.

    Precautions】 (1) Bleeding: For severe or life-threatening bleeding, stivarga is permanently terminated. (2) ** Toxicity:

    Regorafenib tablets** are discontinued and then reduced or discontinued with stivarga depending on the severity and persistence of the toxicity. (3) Hypertension: Temporary or permanent termination of stivarga for severe or uncontrollable hypertension.

    4) Cardiac ischemia and infarction: Refusal to give stivarga to new or acute ischemic infarction and recovery only after resolution of acute ischemic events. (5) Reversible posterior leukoencephalopathy syndrome (RPLS):

    Terminate stivarga. (6) Perforation or fistula of the gastrointestinal tract: terminate stivarga.

    7) Complications of wound healing: regorafenib tablets ** are sold before surgery to stop stivarga. Terminated in wound dehiscence patients.

    8) Embryonic fetal toxicity: may cause fetal harm. Advise women about potential risks to the fetus.

    Storage] Shading, sealed storage.

  2. Anonymous users2024-02-07

    Regorafenib is the only oral targeted drug for bowel cancer, and it has also passed the targeting of liver cancer**, several versions, the Bangladeshi version of 1,000 to 2,000, and the domestic one is now also under medical insurance, and it only takes 2ooo in my case

Related questions
16 answers2024-04-28

Pargo signed a one-year contract worth nearly $4 million with Dynamo Moscow and will spend the next season in Europe. In addition, $4 million will be after-tax wages, which are paid by the club. >>>More

23 answers2024-04-28

Yes. Each Poetsch watch starts from the source movement, passes the frequency of testing to eliminate substandard products, and uses the S686 two-time movement, which is fully wound and can travel for more than 50 hours in a stationary state. >>>More

10 answers2024-04-28

Because the two of them made movies and got together less and left more, and later Wei was rumored to be flirting with another person on another set, and later developed a relationship, anyway, the woman changed her mind, and Jonny broke up with her. This was said in the 10th screening room of Depp in a previous issue, and you can check it out if you are interested.